BACH1 as a key driver in rheumatoid arthritis fibroblast-like synoviocytes identified through gene network analysis
Life Science Alliance · 2025-01 · 8 (1) · e202402808
DOI: 10.26508/lsa.202402808 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Science Alliance, online erschienen am 28.10.2024. Verfasst von Aurelien Pelissier und 4 weiteren Autor:innen. Beteiligte Einrichtung: IBM Research Europe, Eschlikon, Switzerland. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Synoviocytes, Basic-Leucine Zipper Transcription Factors, Gene Regulatory Networks. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAMS NIH HHS, EC | European Research Council, HHS | NIH | All of Us Research Program.
Abstract (Originalsprache)
RNA-sequencing and differential gene expression studies have significantly advanced our understanding of pathogenic pathways underlying rheumatoid arthritis (RA). Yet, little is known about cell-specific regulatory networks and their contributions to disease. In this study, we focused on fibroblast-like synoviocytes (FLS), a cell type central to disease pathogenesis and joint damage in RA. We used a strategy that computed sample-specific gene regulatory networks to compare network properties between RA and osteoarthritis FLS. We identified 28 transcription factors (TFs) as key regulators central to the signatures of RA FLS. Six of these TFs are new and have not been previously implicated in RA through ex vivo or in vivo studies, and included BACH1, HLX, and TGIF1. Several of these TFs were found to be co-regulated, and BACH1 emerged as the most significant TF and regulator. The main BACH1 targets included those implicated in fatty acid metabolism and ferroptosis. The discovery of BACH1 was validated in experiments with RA FLS. Knockdown of BACH1 in RA FLS significantly affected the gene expression signatures, reduced cell adhesion and mobility, interfered with the formation of thick actin fibers, and prevented the polarized formation of lamellipodia, all required for the RA destructive behavior of FLS. This study establishes BACH1 as a central regulator of RA FLS phenotypes and suggests its potential as a therapeutic target to selectively modulate RA FLS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- IBM Research Europe, Eschlikon, Switzerland.
- Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland.
- Division of Rheumatology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- IBM Research Europe, Eschlikon, Switzerland maria.rodriguezmartinez@yale.edu.
- Division of Rheumatology, Icahn School of Medicine at Mount Sinai, New York, NY, USA percio.gulko@mssm.edu.
ORCID-Profile: María Rodríguez Martínez
Förderung
- NIAMS NIH HHS
- EC | European Research Council
- HHS | NIH | All of Us Research Program
Zitieren
APA
Pelissier, A., Laragione, T., Harris, C., Rodríguez Martínez, M., & Gulko, P. S. (2025). BACH1 as a key driver in rheumatoid arthritis fibroblast-like synoviocytes identified through gene network analysis. Life Science Alliance, 8(1), e202402808. https://doi.org/10.26508/lsa.202402808
Vancouver
Pelissier A, Laragione T, Harris C, Rodríguez Martínez M, Gulko PS. BACH1 as a key driver in rheumatoid arthritis fibroblast-like synoviocytes identified through gene network analysis. Life Science Alliance. 2025;8(1):e202402808. doi:10.26508/lsa.202402808
BibTeX
@article{Pelissier2025,
author = {Pelissier, Aurelien and Laragione, Teresina and Harris, Carolyn and Rodríguez Martínez, María and Gulko, Percio S},
title = {BACH1 as a key driver in rheumatoid arthritis fibroblast-like synoviocytes identified through gene network analysis},
journal = {Life Science Alliance},
year = {2025},
volume = {8},
number = {1},
pages = {e202402808},
doi = {10.26508/lsa.202402808}
}
EUVIMED